|
26
|
|
678
|
-1
|
-0.1%
|
$15B
|
|
|
27
|
|
675
|
-18
|
-3%
|
$12.2B
|
|
|
28
|
|
634
|
-22
|
-3%
|
$16.1B
|
|
|
29
|
|
601
|
+115
|
+24%
|
$20B
|
|
|
30
|
|
601
|
-9
|
-1%
|
$9.43B
|
|
|
31
|
|
566
|
+2
|
+0.4%
|
$10.3B
|
|
|
32
|
|
556
|
+10
|
+2%
|
$7.68B
|
|
|
33
|
|
544
|
+41
|
+8%
|
$12.7B
|
|
|
34
|
iShares US Medical Devices ETF
|
505
|
-7
|
-1%
|
$1.53B
|
|
|
35
|
|
489
|
+62
|
+15%
|
$6.41B
|
|
|
36
|
|
468
|
+60
|
+15%
|
$8.34B
|
|
|
37
|
|
451
|
-34
|
-7%
|
$10.8B
|
|
|
38
|
|
447
|
+64
|
+17%
|
$7.97B
|
|
|
39
|
|
417
|
+72
|
+21%
|
$8.52B
|
|
|
40
|
|
409
|
+94
|
+30%
|
$33.7B
|
|
|
41
|
|
405
|
+5
|
+1%
|
$4.34B
|
|
|
42
|
Bio-Rad Laboratories Class A
|
400
|
+5
|
+1%
|
$5.7B
|
|
|
43
|
|
391
|
+59
|
+18%
|
$7.27B
|
|
|
44
|
|
384
|
+18
|
+5%
|
$6.08B
|
|
|
45
|
|
383
|
-9
|
-2%
|
$4.99B
|
|
|
46
|
|
377
|
-10
|
-3%
|
$2.4B
|
|
|
47
|
|
375
|
+9
|
+2%
|
$2.6B
|
|
|
48
|
|
375
|
-41
|
-10%
|
$2.31B
|
|
|
49
|
|
370
|
+36
|
+11%
|
$5.23B
|
|
|
50
|
|
367
|
+31
|
+9%
|
$8.44B
|
|